Please use this identifier to cite or link to this item: http://hdl.handle.net/11718/24297
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHiggins, Matthew J.
dc.contributor.authorYan, Xin
dc.contributor.authorChatterjee, Chirantan
dc.date.accessioned2021-10-10T11:43:38Z
dc.date.available2021-10-10T11:43:38Z
dc.date.issued2020-09-12
dc.identifier.citationHiggins, M. J., Yan, X., & Chatterjee, C. (2021). Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling. Research policy, 50(1), 104126.en_US
dc.identifier.otherhttps://doi.org/10.1016/j.respol.2020.104126
dc.identifier.urihttp://hdl.handle.net/11718/24297
dc.description.abstractWe provide causal evidence that regulation induced product shocks significantly impact aggregate demand and firm performance in pharmaceutical markets. Event study results suggest an average loss between $569 million and $882 million. Affected products lose, on average, $186 million over their remaining effective patent life. This leaves a loss of between $383 million and $696 million attributable to declines in future innovation. Our findings complement research that shows drugs receiving expedited review are more likely to suffer from regulation induced product shocks. Thus, it appears we may be trading off quicker access to drugs today for less innovation tomorrow. Results remain robust to variation across types of relabeling, market sizes, and levels of competition.en_US
dc.language.isoenen_US
dc.publisherResearch Policy
dc.subjectRegulatory shocksen_US
dc.subjectDrug safety label changesen_US
dc.subjectPharmaceutical innovationen_US
dc.titleUnpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabelingen_US
dc.typeArticleen_US
Appears in Collections:Journal Articles

Files in This Item:
File Description SizeFormat 
Unpacking the effects of adverse regulatory events_Evidence from pharmaceutical relabeling.pdf
  Restricted Access
Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling941.37 kBAdobe PDFView/Open Request a copy


Items in IIMA Institutional Repository are protected by copyright, with all rights reserved, unless otherwise indicated.